Allergan Aesthetics, a subsidiary of AbbVie, has announced the launch of the Faces of Natrelle® Testimonial Program, aimed at empowering women by sharing their personal experiences with Natrelle® breast implants. This initiative invites eligible patients across the United States who have undergone breast augmentation or reconstruction to contribute their stories, enhancing public understanding and support for those considering similar procedures.
February 3, 2026, marked the official announcement from the company’s headquarters in Irvine, California. The program encourages women aged 22 and older to submit photos or videos, alongside written testimonials detailing their journeys with Natrelle® Breast Implants. “Faces of Natrelle® is about honoring the stories, the decisions, and the transformations of women with breast implants,” said Nicole Mowad-Nassar, President of Global Allergan Aesthetics. She emphasized that despite the popularity of breast procedures in the U.S., they remain clouded by outdated perceptions and a culture of silence.
The initiative aims to address these misconceptions by showcasing the diverse experiences of women. Each journey, whether stemming from personal choice through augmentation or medical necessity through reconstruction, carries its own unique challenges and emotions. By sharing their narratives, participants can provide clarity and confidence for others navigating their own decisions about breast aesthetics.
Women who have undergone Natrelle® breast augmentation may also qualify for a financial incentive. Those who are members of the Allē loyalty program and whose contributions are selected will receive $500 in Allē Gift Cards, subject to terms and conditions. Reconstruction patients, while not eligible for compensation, are encouraged to participate to inspire and support the broader community.
To participate, women can learn more about their eligibility and apply through the dedicated websites: faces.natrelle.com/augmentation for augmentation patients and faces.natrelle.com/reconstruction for reconstruction patients. The program reflects a growing cultural shift towards transparency and empowerment in cosmetic surgery, aligning with the broader mission of Allergan Aesthetics to foster conversations around aesthetics.
As the leading breast implant brand selected by plastic surgeons, according to survey data from September 2025, Natrelle® aims to provide comprehensive information and support for patients considering breast surgery. For more details on treatment options or to find a provider, individuals can visit natrelle.com or follow the brand on Instagram at @natrellebreastaugmentation and @natrellebreastreconstruction.
The announcement of the Faces of Natrelle® Testimonial Program highlights Allergan Aesthetics’ commitment to not only delivering innovative products but also to fostering an environment where women’s voices are amplified and celebrated in their aesthetic journeys.
